American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 587.e1-587.e8 , December 2009

Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants

Presented, in part, at the 35th Annual Meeting of the Fetal and Neonatal Physiologic Society, Maastricht, The Netherlands, June 22-25, 2008; the Annual Congress of the European Academy of Paediatrics, Barcelona, Spain, Oct. 7-10, 2006; and the Annual Meeting of the Pediatric Academic Societies, San Francisco, CA, April 29-May 2, 2006.

  • Jasper V. Been, MD

      Affiliations

    • Department of Pediatrics, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Center, Maastricht, The Netherlands
    • ,
  • Ingrid G.I.J.G. Rours, MD

      Affiliations

    • Department of Pediatric Infectious Diseases and Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Department Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Department of Pediatrics, Maasstad Hospital, Rotterdam, The Netherlands
    • ,
  • René F. Kornelisse, MD, PhD

      Affiliations

    • Department of Pediatrics, Division of Neonatology, Erasmus Medical Center–Sophia Children's Hospital, Rotterdam, The Netherlands
    • ,
  • Valéria Lima Passos, PhD

      Affiliations

    • Department of Methodology and Statistics, Maastricht University, Maastricht, The Netherlands
    • ,
  • Boris W. Kramer, MD, PhD

      Affiliations

    • Department of Pediatrics, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Center, Maastricht, The Netherlands
    • ,
  • Tom A.J. Schneider, MD

      Affiliations

    • Department of Obstetrics and Prenatal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Ronald R. de Krijger, MD, PhD

      Affiliations

    • Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • ,
  • Luc J.I. Zimmermann, MD, PhD

      Affiliations

    • Department of Pediatrics, School for Oncology and Developmental Biology (GROW), Maastricht University Medical Center, Maastricht, The Netherlands

Received 12 January 2009 ,Revised 3 April 2009 ,Accepted 4 June 2009.

References 

  1. Lahra MM, Jeffery HE. A fetal response to chorioamnionitis is associated with early survival after preterm birth. Am J Obstet Gynecol. 2004;190:147–151
  2. De Felice C, Toti P, Laurini RN, et al. Early neonatal brain injury in histologic chorioamnionitis. J Pediatr. 2001;138:101–104
  3. Mehta R, Nanjundaswamy S, Shen-Shwarz S, Petrova A. Neonatal morbidity and placental pathology. Indian J Pediatr. 2006;73:25–28
  4. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996;97:210–215
  5. Holcroft CJ, Askin FB, Patra A, Allen MC, Blakemore KJ, Graham EM. Are histopathologic chorioamnionitis and funisitis associated with metabolic acidosis in the preterm fetus?. Am J Obstet Gynecol. 2004;191:2010–2015
  6. Dammann O, Leviton A, Bartels DB, Dammann CE. Lung and brain damage in preterm newborns (Are they related? How? Why?). Biol Neonate. 2004;85:305–313
  7. Salafia CM, Minior VK, Rosenkrantz TS, et al. Maternal, placental and neonatal associations with early germinal matrix/intraventricular hemorrhage in infants born before 32 weeks' gestation. Am J Perinatol. 1995;12:429–436
  8. De Felice C, Toti P, Parrini S, et al. Histologic chorioamnionitis and severity of illness in very low birth weight newborns. Pediatr Crit Care Med. 2005;6:298–302
  9. Been JV, Zimmermann LJ. Histologic chorioamnionitis and respiratory outcome in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F218–F225
  10. Dempsey E, Chen MF, Kokottis T, Vallerand D, Usher R. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis. Am J Perinatol. 2005;22:155–159
  11. Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: a 10 year hospital cohort study. Arch Dis Child Fetal Neonatal Ed. 2009;94:F13–F16
  12. Kosuge S, Ohkuchi A, Minakami H, et al. Influence of chorioamnionitis on survival and morbidity in singletons live-bron at < 32 weeks gestation. Acta Obstet Gynecol Scand. 2000;79:861–865
  13. Andrews WW, Goldenberg RL, Faye-Petersen O, Cliver S, Goepfert AR, Hauth JC. The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants. Am J Obstet Gynecol. 2006;195:803–808
  14. Ohyama M, Itani Y, Yamanaka M, et al. Re-evaluation of chorioamnionitis and funisitis with a special reference to subacute chorioamnionitis. Hum Pathol. 2002;33:183–190
  15. Kaukola T, Tuimala J, Herva R, Kingsmore S, Hallman M. Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol. 2009;200:100.e1–100.e8
  16. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns—dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004;79:1–15
  17. Kramer BW, Kaemmerer U, Kapp M, et al. Decreased expression of angiogenic factors in placentas with chorioamnionitis after preterm birth. Pediatr Res. 2005;58:607–612
  18. Limperopoulos C, Bassan H, Sullivan NR, et al. Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics. 2008;121:758–765
  19. De Felice C, De Capua B, Costantini D, et al. Recurrent otitis media with effusion in preterm infants with histologic chorioamnionitis—a 3 years follow-up study. Early Hum Dev. 2008;84:667–671
  20. Kumar R, Yu Y, Story RE, et al. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study. J Allergy Clin Immunol. 2008;121:878-84.e6
  21. Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol. 1973;1:145–152
  22. Volpe JJ. Hypoxic-ischemic encephalopathy: clinical aspects. In:  Volpe JJ editors. Neurology of the newborn. Philadelphia: Saunders; 2001;p. 331–394
  23. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis (Therapeutic decisions based upon clinical staging). Ann Surg. 1978;187:1–7
  24. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6:435–448
  25. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med. 2009;14:2–7
  26. Chaiworapongsa T, Hong JS, Hull WM, Romero R, Whitsett JA. Amniotic fluid concentration of surfactant proteins in intra-amniotic infection. J Matern Fetal Neonatal Med. 2008;21:663–670
  27. Elimian A, Verma U, Beneck D, Cipriano R, Visintainer P, Tejani N. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol. 2000;96:333–336
  28. Goldenberg RL, Andrews WW, Faye-Petersen OM, Cliver SP, Goepfert AR, Hauth JC. The Alabama Preterm Birth Study: corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection. Am J Obstet Gynecol. 2006;195:1020–1024
  29. Kallapur SG, Kramer BW, Moss TJ, et al. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am J Physiol Lung Cell Mol Physiol. 2003;284:L633–L642
  30. Been JV, Kramer BW, Zimmermann LJ. Antenatal corticosteroids to prevent preterm birth. Lancet. 2009;373:894
  31. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement. 1994;12:1–24
  32. Park CW, Moon KC, Park JS, Jun JK, Romero R, Yoon BH. The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications. Placenta. 2009;30:56–61
  33. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003;13:102–109
  34. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH. Endotoxin-induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am J Respir Crit Care Med. 2005;171:73–77
  35. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH. Antenatal betamethasone changes cord blood monocyte responses to endotoxin in preterm lambs. Pediatr Res. 2004;55:764–768
  36. Been JV, Kramer BW, Zimmermann LJ. In utero and early-life conditions and adult health and disease. N Engl J Med. 2008;359:1523–1524

 Reprints not available from the authors.

 This study was supported in part by the Revolving Fund, Erasmus University Medical Center, Rotterdam, The Netherlands. J.V.B. is supported by a Profileringsfonds Grant from the Maastricht University Medical Center.

 The first 2 authors contributed equally to the study and article.

 Cite this article as: Been JV, Rours IGIJG, Kornelisse RF, et al. Histologic chorioamnionitis, fetal involvement, and antenatal steroids: effects on neonatal outcome in preterm infants. Am J Obstet Gynecol 2009;201:587.e1-8.

PII: S0002-9378(09)00647-4

doi: 10.1016/j.ajog.2009.06.025

American Journal of Obstetrics & Gynecology
Volume 201, Issue 6 , Pages 587.e1-587.e8 , December 2009

Article Tools